.
.
.
Ed Silverman
Pharmalot
01/05/09

Yesterday, we wrote that Charles Nemeroff, the controversial psychiatry professor at Emory University in Atlanta, had just purchased a $1.9 million, six-bedroom, seven-bath home in the Coconut Grove section of Miami, as he prepares for his new job at the University of Miami’s Miller School of Medicine, where he’ll chair the psychiatry department.

For those who were wondering about his home in Atlanta, you won’t be surprised that it’s up for sale and the going rate is $1.25 million. You can take a tour here. This one sports just five bedrooms, but still plenty of room for storing consulting materials.

Nemeroff wound up in the spotlight thanks to the US Senate Finance Committee, which is trying to force universities and the NIH to more aggressively monitor alleged conflicts. Nemeroff was accepting sizeable consulting fees from Glaxo at the same that he was the primary investigator on an NIH-funded grant for research into a Glaxo drug (background here).

The probe prompted Emory to suspend Nemeroff’s work on an NIH grant and asked him to step down as chair of psychiatry while it studied his conduct. And the Department of Health and Human Services Office of Inspector General began an inquiry into Emory’s handling of the matter. Meanwhile, Pascal Goldschmidt, the Miller school dean, recently told The Miami Herald that he read reports from Emory about Nemeroff’s activities and found nothing to indicate that payments the psychiatrist received had in any way influenced his research results